A model for the design and evaluation of algorithms for closed-loop cardiovascular therapy

Developing a clinically useful closed-loop drug delivery system can be extremely time consuming and costly. One approach to reducing the time and cost associated with developing closed-loop systems is to reduce the number of animal experiments and perform an extensive set of simulation studies. Through simulations, a closed-loop controller's performance can be evaluated over a complete spectrum of the patient population, including boundary conditions. Simulation studies are repeatable, offering significant advantages in comparing modifications in control algorithms. Finally, simulation studies can be performed in a fraction of the time required for animal studies, at a fraction of the cost. We have developed a simulator, that included a nonlinear pulsatile-flow cardiovascular model, a physiological regulatory mechanism, and the pharmacology of four frequently titrated cardiovascular drugs. This simulator has already been used in the design and evaluation of two closed-loop algorithms-a self-tuning regulator (STR) and a multiple model adaptive controller (MMAC)-for blood pressure control during and after cardiac surgery.

[1]  Howard Jay Chizeck,et al.  Self-tuning controller for drug delivery systems , 1988 .

[2]  S. Minatoguchi,et al.  Differential vasodilator effect of nitroglycerin on systemic capacitance and resistance vessels in anesthetized dogs, and the mechanism of its action--a study by measuring mean circulatory pressure and total peripheral resistance. , 1989, Japanese circulation journal.

[3]  K.J. Gingrich,et al.  Modeling the hemodynamic response to dopamine in acute heat failure , 1991, IEEE Transactions on Biomedical Engineering.

[4]  R J Roy,et al.  A circulatory model for combined nitroprusside-dopamine therapy in acute heart failure. , 1990, Medical progress through technology.

[5]  P. Armstrong,et al.  Pharmacokinetic‐Hemodynamic Studies of Intravenous Nitroglycerin in Congestive Cardiac Failure , 1980, Circulation.

[6]  Rob J. Roy,et al.  Modeling the hemodynamic response to dopamine in acute heart failure , 1988, Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[7]  N. T. Smith,et al.  Interactions among Ventilation, the Circulation and the Uptake and Distribution of Halothane—Use of a Hybrid Computer Multiple Model: I. The Basic Model , 1981, Anesthesiology.

[8]  R. N. Brogden,et al.  Intravenous glyceryl trinitrate (nitroglycerin). A review of its pharmacological properties and therapeutic efficacy. , 1984, Drugs.

[9]  C. Leier,et al.  Comparative Systemic and Regional Hemodynamic Effects of Dopamine and Dobutamine in Patients with Cardiomyopathic Heart Failure , 1978, Circulation.

[10]  A. Yacobi,et al.  Nitroglycerin pharmacokinetics after intravenous infusion in normal subjects. , 1981, Journal of pharmaceutical sciences.

[11]  N. T. Smith,et al.  Interactions among Ventilation, the Circulation, and the Uptake and Distribution of Halothane—Use of a Hybrid Computer Multiple Model: II. Spontaneous vs. Controlled Ventilation, and the Effects of CO2 , 1981, Anesthesiology.

[12]  N. T. Smith,et al.  Improved safety and efficacy in adaptive control of arterial blood pressure through the use of a supervisor , 1992, IEEE Transactions on Biomedical Engineering.

[13]  W. Stigelman,et al.  Goodman and Gilman's the Pharmacological Basis of Therapeutics , 1986 .

[14]  James F. Martin,et al.  Multiple-Model Adaptive Control of Blood Pressure Using Sodium Nitroprusside , 1987, IEEE Transactions on Biomedical Engineering.

[15]  B. Robinson,et al.  Comparative dilator effect of verapamil and sodium nitroprusside in forearm arterial bed and dorsal hand veins in man: functional differences between vascular smooth muscle in arterioles and veins. , 1979, Cardiovascular research.

[16]  D. G. Watts,et al.  Steady state pharmacokinetic haemodynamic studies of intravenous nitroglycerin in congestive cardiac failure. , 1983, British journal of clinical pharmacology.

[17]  James F. Martin,et al.  A new cardiovascular model for real-time applications , 1986 .

[18]  W. Chitwood,et al.  Multicenter trial of automated nitroprusside infusion for postoperative hypertension. Titrator Multicenter Study Group. , 1992, The Annals of thoracic surgery.

[19]  V C Rideout,et al.  The use of multiple models in cardiovascular system studies: transport and perturbation methods. , 1968, IEEE transactions on bio-medical engineering.

[20]  J. Tyberg,et al.  Resistance and volume changes caused by nitroprusside in the dog. , 1979, The American journal of physiology.

[21]  L. Cohn,et al.  Automated control of postoperative hypertension: a prospective, randomized multicenter study. , 1989, The Annals of thoracic surgery.

[22]  C. Leier,et al.  The relationship between plasma dobutamine concentrations and cardiovascular responses in cardiac failure. , 1979, The American journal of medicine.

[23]  R. Goldberg,et al.  Central and regional hemodynamic effects of intravenous isosorbide dinitrate, nitroglycerin and nitroprusside in patients with congestive heart failure. , 1981, The American journal of cardiology.

[24]  N. T. Smith,et al.  Supervisory adaptive control of arterial pressure during cardiac surgery , 1992, IEEE Transactions on Biomedical Engineering.

[25]  T. Whitsett,et al.  Relationship of Pharmacokinetic and Pharmacodynamic Properties of the Organic Nitrates , 1988, Clinical pharmacokinetics.